Sonoma Pharmaceuticals, Inc. (SNOA)
| Market Cap | 10.11M |
| Revenue (ttm) | 12.49M |
| Net Income (ttm) | -5.80M |
| Shares Out | 3.10M |
| EPS (ttm) | -2.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,322 |
| Open | 3.29 |
| Previous Close | 3.35 |
| Day's Range | 3.20 - 3.59 |
| 52-Week Range | 2.55 - 13.36 |
| Beta | 1.00 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Jul 13, 2022 |
About SNOA
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of new and old sc...
Financial Performance
In 2020, SNOA's revenue was $18.63 million, an increase of 3.91% compared to the previous year's $17.93 million. Losses were -$3.95 million, 19.4% more than in 2019.
Financial StatementsNews
Why Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?
Sonoma Pharmaceuticals (SNOA) stock is getting a boost on Tuesday after the company revealed positive disinfectant news from the EPA. The post Why Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?
Best Penny Stocks to Buy Today? 3 to Watch on May 3rd
What to know about buying penny stocks on May 3rd The post Best Penny Stocks to Buy Today? 3 to Watch on May 3rd appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the...
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) ...
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GER...
Sonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South Africa
Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) has launched Microdox, an urinary tract infection catheter and bladder rinse in New Zealand, Australia, and South Africa. Microdox is a super-oxidized solution ...
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia an...
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) ...
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applica...
Sonoma Pharma Expands Its Partner Network For Oral, Dental Products In US & China
Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) has added Salus Medical as an additional distribution partner in the U.S for dental care. The Company has also expanded its oral and dental care lines to China ...
Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) ...
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applica...
Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applica...
Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in...
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applica...
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the A...
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applica...
Why SNOA Stock Is Getting a Bezos-Sized Boost Today
Today, investors in Sonoma Pharmaceuticals and SNOA stock are seeing impressive gains as the company launches its products on Amazon. The post Why SNOA Stock Is Getting a Bezos-Sized Boost Today appeare...
Here's why Sonoma Pharmaceuticals is up 70% on Tuesday morning
Shares of Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) jumped 70% in premarket trading on Tuesday as the company launched its first-ever over-the-counter products on Amazon. Sonoma debuts in the OTC market...
Why Are Sonoma Pharma Shares Rallying Today?
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) has announced the OTC consumer launch of Regenacyn Advanced Scar Gel and Ocucyn Eyelid & Eyelash Cleanser on Amazon.com and MucoClyns on Amazon sites in Europe. ...
Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused ...
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applica...
Why Sonoma Pharmaceuticals Shares Are Trading Lower Today
Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) is trading significantly lower Friday amid possible profit taking after the stock surged Thursday following the company's launch of two new dental products. Son...
Why Sonoma Pharmaceuticals Shares Are Surging Higher Today
Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) is surging higher Thursday after the company announced it launched two new dental products. Sonoma Pharmaceuticals launched OroGenix Oral Hygiene Rinse, which ...
SNOA Stock: The Product Launches Sending Sonoma Pharmaceuticals Soaring Today
Sonoma Pharmaceuticals (SNOA) stock is running higher on Thursday following the launch of new dental products from the company. The post SNOA Stock: The Product Launches Sending Sonoma Pharmaceuticals S...
Why Sonoma Pharma (SNOA) Stock Skyrocketing On Thursday
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) stock doubled in reaction to the launch of two new dental products. OroGenix Oral Hygiene Rinse is Sonoma's second dental product in the U.S. and was developed ...
Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a...
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) ...
Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results
WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applica...
Why Sonoma Pharmaceuticals Shares Are Getting Hammered Today
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) shares are trading lower by 18.6% at $6.25 after the company reported fourth-quarter EPS and sales results were down year-over-year. Sonoma Pharmaceuticals repor...